Technetium-99m-L,L-ethylenedicysteine (Tc-99m-LL-EC) is a new renal im
aging agent with pharmacokinetic properties reported to be slightly su
perior to those of Tc-99m-mercaptoacetyltriglycine (Tc-99m-MAG3); howe
ver, to better define the potential of the enantiomer Tc-99m-DD-EC and
the diastereomer Tc-99m-DL-EC as renal imaging agents, we compared th
e three EC stereoisomers with I-131-orthoiodohippurate (OIH) in a seri
es of rats and humans. Methods: Each Tc-99m-EC stereoisomer was coinje
cted with OIH in six Sprague-Dawley rats for measurements of clearance
and extraction fraction. Each stereoisomer was also coinjected with O
IH in three human volunteers followed by sequential imaging, plasma cl
earance measurements and timed urine collections. Results: Technetium-
99m-DD-EC had the highest clearance and extraction efficiency in rats
(p less than or equal to 0.02). In humans, image quality was good with
all three agents. The clearance ratio (EC/OIH) was 82% +/- 8% for Tc-
99m-DD-EC compared to 70% +/- 3% and 40% +/- 5% for Tc-99m-LL-EC and T
c-99m-DL-EC, respectively. Technetium-99m-DD and Tc-99m-LL-EC were exc
reted more rapidly than Tc-99m-DL-EC. Conclusion: Technetium-99m-DD-EC
has excellent imaging properties and the data suggest that its cleara
nce may approach that of OIH more closely than any other Tc-99m renal
agent. A potential limitation is the fact that both Tc-99m-DD and LL-E
C exist in dianionic (80%) and monoanionic (20%) forms at physiologica
l pH and it is unlikely that these two forms have the same clearance o
r protein binding affinity.